In this interview, Joe Hazelton, President and COO of Dyadic Applied BioSolutions, Inc. (NASDAQ: DYAI), discusses the Company's product-centric strategy, commercialization efforts, strategic partnerships, and opportunities across Life Sciences, Food ...
Hims & Hers (HIMS) extended its rally this week, surging for a second straight session as investors reacted to signals that U.S. regulators may take a more flexible approach toward ...